Related Experiment Videos
An assessment of the cardiovascular sympathectomy induced by guanethidine
Insights
Guanethidine treatment depleted cardiovascular catecholamines, suggesting sympathectomy. However, functional tests showed unimpaired noradrenergic nerve capacity, indicating a dissociation in guanethidine
Area of Science:
- Pharmacology
- Neuroscience
- Cardiovascular Research
Background:
- Guanethidine is a known sympathectomy-inducing agent.
- Catecholamine depletion in cardiovascular tissues is a hallmark of sympathectomy.
- Understanding the functional consequences of guanethidine-induced sympathectomy is crucial.
Purpose of the Study:
- To investigate the effects of guanethidine on cardiovascular catecholamine levels.
- To assess the functional capacity of noradrenergic nerves after guanethidine treatment.
- To explore the dissociation between physical and functional measures of sympathectomy.
Main Methods:
- Administered guanethidine (30 mg/kg, i.p. daily for 6 weeks) to rats.
- Utilized fluorescence histochemistry and catecholamine determinations to quantify tissue catecholamines.
- Performed pressor response tests using physostigmine and carotid occlusion.
Main Results:
- Guanethidine treatment profoundly reduced cardiovascular catecholamines.
- Catecholamine levels showed evidence of return within 8 weeks post-treatment.
- Pressor responses to physostigmine and carotid occlusion remained unaltered, indicating functional noradrenergic capacity.
- Observed supersensitivity to exogenous noradrenaline.
Conclusions:
- Guanethidine induces a reduction in cardiovascular catecholamines, consistent with sympathectomy.
- Despite catecholamine depletion, functional tests suggest unimpaired noradrenergic nerve activity.
- A dissociation exists between physical and functional assessments of guanethidine-induced sympathectomy.
Abstract:
Guanethidine treatment of rate (30 mg kg(-1), i.p. daily for 6 weeks) produced a profound reduction in the catecholamine present (as indicated by fluorescence histochemistry and catecholamine determinations) in tissues taken from the cardiovascular system, but there was evidence of the return of catecholamines within 8 weeks. While these changes are consistent with a sympathectomy, the unaltered pressor responses to physostigmine (100 mug kg(-1), i.v.) and to carotid occlusion indicate an unimpaired functional capacity of noradrenergic nerves supplying the cardiovascular system. Although part of the response may be attributed to the unaffected adrenal medulla enhanced by the presence of considerable supersensitivity as shown to exogenous noradrenaline, there would appear to be a dissociation between the results obtained from physical and functional tests of the sympathectomy induced by guanethidine.